Sachie Nakatani

Dr. Sachie Nakatani

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Medicines
Verified
Journal Article
Open access
PDF file
TAToshiaki Ara
Toshiaki Ara
SNSachie Nakatani
Sachie Nakatani
KKKenji Kobata
Kenji Kobata
NSNorio Sogawa
Norio Sogawa
CSChiharu Sogawa
Chiharu Sogawa
The oral inflammatory diseases are divided into two types: acute and chronic inflammatory diseases. In this review, we summarize the biological efficacy of herbal medicine, natural products, and their active ingredients against acute and chronic inflammatory diseases in the oral region, especially stomatitis and periodontitis. We review the effects of herbal medicines and a biscoclaurin alkaloid preparation, cepharamthin, as a therapy against stomatitis, an acute inflammatory disease. We also summarize the effects of herbal medicines and natural products against periodontitis, a chronic inflammatory disease, and one of its clinical conditions, alveolar bone resorption. Recent studies show that several herbal medicines such as kakkonto and ninjinto reduce LPS-induced PGE 2 production by human gingival fibroblasts. Among herbs constituting these herbal medicines, shokyo (Zingiberis Rhizoma) and kankyo (Zingiberis Processum Rhizoma) strongly reduce PGE 2 production. Moreover, anti-osteoclast activity has been observed in some natural products with anti-inflammatory effects used against rheumatoid arthritis such as carotenoids, flavonoids, limonoids, and polyphenols. These herbal medicines and natural products could be useful for treating oral inflammatory diseases.

Verified
Journal Article
Open access
PDF file
SNSachie Nakatani
Sachie Nakatani
YHYasuhiro Horimoto
Yasuhiro Horimoto
NNNatsumi Nakabayashi
Natsumi Nakabayashi
MKMayumi Karasawa
Mayumi Karasawa
MWMasahiro Wada
Masahiro Wada
KKKenji Kobata
Kenji Kobata
Endogenous polyamines such as putrescine (Put), spermidine (Spd), and spermine (Spm) affect adipocyte differentiation. In this study, we investigated the effect of exogenously supplemented polyamines on mouse adipocyte differentiation and anti-obesity actions in vitro and in vivo. The preadipocyte cell line, 3T3-L1, was cultured with Put, Spd, or Spm, and lipid accumulation in the cells was measured by Oil Red O staining. Lipid accumulation was significantly suppressed by Spm. Suppression of CCAAT/enhancer binding protein α mRNA by Spm suggested that the decreased lipid accumulation was due to delaying the cell differentiation. The body weight and fat of obese mice induced with a high-fat diet were reduced by oral ingestion of Spm. In conclusion, oral supplementation of Spm has the ability to prevent obesity through inhibition of adipocyte differentiation.

1 December 2017 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
YKYoshifumi Kimira
Yoshifumi Kimira
HOHaruka Odaira
Haruka Odaira
KNKaho Nomura
Kaho Nomura
YTYuri Taniuchi
Yuri Taniuchi
NINaoki INOUE
Naoki INOUE
HMHiroshi MANO
Hiroshi MANO
Prolyl-hydroxyproline (Pro-Hyp) is one of the major constituents of collagen-derived dipeptides. We previously reported that Pro-Hyp promotes the differentiation of osteoblasts by increasing Runx2, osterix and Col1α1 mRNA expression levels. Here, to elucidate the mechanism of Pro-Hyp promotion of osteoblast differentiation, we focus on the involvement of Foxo1 in osteoblast differentiation via Runx2 regulation and the role of Foxg1 in Foxo1 regulation. The addition of Pro-Hyp had no effect on MC3T3-E1 cell proliferation in Foxo1- or Foxg1-knockdown cells. In Foxo1-knockdown cells, the addition of Pro-Hyp increased ALP activity, but in Foxg1-knockdown cells, it had no effect on ALP activity. An enhancing effect of Pro-Hyp on the Runx2 and osterix expression levels was observed in Foxo1-knockdown cells. However, no enhancing effect of Pro-Hyp on osteoblastic gene expression was observed when Foxg1 was knocked down. These results demonstrate that Pro-Hyp promotes osteoblastic MC3T3-E1 cell differentiation and upregulation of osteogenic genes via Foxg1 expression.

Verified
Journal Article
Open access
PDF file
Hiroshi SakagamiHiroshi Sakagami
Hiroshi Sakagami
SNSachie Nakatani
Sachie Nakatani
AEAyame Enomoto
Ayame Enomoto
SOSana Ota
Sana Ota
MKMiku Kaneko
Miku Kaneko
TOTakaaki Oizumi
Takaaki Oizumi
Efficient utilization of alkaline extracts of several plants for the treatment of oral diseases has been reported. To investigate the mechanism of anti-inflammatory activity of alkaline extract of the leaves of Sasa sp. (SE), multi-omics analysis using metabolomics and DNA array was performed. Human gingival fibroblasts (HGFs) were treated for IL-1β to induce inflammation (detected by PGE2 production in culture medium) in the presence or absence of SE. Both IL-1β and SE showed slight hormetic growth stimulation against HGF. SE inhibited PGE2 production dose- and time-dependently. Its inhibitory action was more pronounced by first treating the cells with SE, rather than with IL-1β. At 3 h after IL-1β treatment, 18 amino acids (except cysteine and glutamic acid), total glutathione (GSH, GSSG, Cys-GSH disulfide), Met-sulfoxide, 5-oxoproline, and SAM declined, whereas DNA expressions of AKT, CASP3, and CXCL3 were elevated. These changes were reversed by simultaneous treatment with SE. The present study suggests that the anti-inflammatory action of SE is mediated via various metabolic pathways for cell survival, apoptosis, and leukocyte recruitment.

26 April 2012 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
YSYuusuke Sekiguchi
Yuusuke Sekiguchi
HMHiroshi MANO
Hiroshi MANO
SNSachie Nakatani
Sachie Nakatani
JSJun Shimizu
Jun Shimizu
KKKenji Kobata
Kenji Kobata
MWMasahiro Wada
Masahiro Wada
Background: Salacia reticulata(SR) is a plant native to Sri Lanka. In ayurvedic medicine, SR bark preparations, taken orally, are considered effective in the treatment of rheumatism and diabetes. We investigated the ability of SR leaves (SRL) to inhibitin vitrothe interleukin-1β (IL-1β)-activated proliferation of synoviocyte-like cells derived from rheumatoid arthritis model mice.Findings: Inflammatory synovial tissues were harvested from type II collagen antibody-induced arthritic mice. From these tissues, a synoviocyte-like cell line was established and named MTS-C H7. To determine whether SRL can suppress cell proliferation and gene expression in MTS-C H7 cells, fractionation of the SRL hot-water extract was performed by high-performance liquid chromatography (HPLC), liquid-liquid extraction, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and protease digestion.The 50% inhibitory concentration of the SRL hot-water extract against MTS-C H7 cells proliferation was ~850 μg/mL. Treatment with a low dose (25 μg dry matter per millilitre) of the extract inhibited IL-1β-induced cell proliferation and suppressed the expression of the matrix metalloproteinase (MMP) genes in MTS-C H7 cells. Various polyphenolic fractions obtained from HPLC and the fractions from liquid-liquid extraction did not affect cell proliferation. Only the residual water sample from liquid-liquid extraction significantly affected cell proliferation and the expression of MMP genes. The results of SDS-PAGE and protease digestion experiment showed that low molecular weight proteins present in SRL inhibited the IL-1β-activated cell proliferation.Conclusions: We surmised that the residual water fraction of the SRL extract was involved in the inhibition of IL-1β-activated cell proliferation and regulation of mRNA expression in MTS-C H7 cells. In addition, we believe that the active ingredients in the extract are low molecular weight proteins.

13 October 2025 in FEBS Open Bio
Verified
Journal Article
Open access
SNSachie Nakatani
Sachie Nakatani
HUHiroya Ueda
Hiroya Ueda
AKAyumi Kawata
Ayumi Kawata
YSYuki Sato
Yuki Sato
KIKotomi Inomata
Kotomi Inomata
KKKenji Kobata
Kenji Kobata
Excess extracellular inorganic phosphate ions (Pi) and calcium ions (Ca 2+ ) cause apoptosis and subsequent mineralization of chondrocytes. Here, we investigated the mechanism underlying the effect of these minerals. The chondrogenic cell line ATDC5 was treated with 2 m m Pi and/or Ca 2+ , and apoptosis, mineralization, and intracellular Pi concentrations were determined. Further, Pi‐ and Ca 2+ ‐treated cells were incubated with the Pi transporter (Pit‐1) blocker phosphonoformic acid (PFA), the calcium‐sensing receptor (CaSR) antagonist NPS‐2143, and the CaSR agonist GdCl 3 . Individual addition of Pi and Ca 2+ did not induce apoptosis and mineralization, while combined addition of the minerals induced both. The Pit‐1 blocker and the CaSR antagonist completely inhibited the apoptosis induced by combined addition of Pi and Ca 2+ . Intracellular Pi concentration was remarkably increased by combined addition of Pi and Ca 2+ as compared to the findings for individual addition. The Pit‐1 blocker and CaSR antagonist completely inhibited the increase in intracellular Pi concentration induced by the combined addition of Pi and Ca 2+ . The CaSR agonist considerably increased the intracellular Pi concentration. Our results indicate that excess extracellular Ca 2+ activates CaSR, which induces the intake of excess extracellular Pi through Pit‐1 into ATDC5 cells. The resulting increase in intracellular Pi concentration induces apoptosis.